Senior insider sale
SVP, Chief Technical Officer at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$30.0K
17.61K shares
What this filing means
BENESKI BENJAMIN MACHINAS plans to sell 17.61K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $30.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000842
Officer· SVP, Chief Technical Officer
Since Mar 2026
17.61K
Shares to sell
$30.0K
Approx. market value
16.82K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
1/31/2026
16.82KTotal acquired16.82K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted stock vesting under a registered plan Compensation | 16.82K | — |
| Total | 16.82K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
786.00
Market value
$958.92
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.82K
Market value
$29.1K
2/2/2026
Total
Units
17.61K
Value
$30.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/17/2025 | 786.00 | $958.92 | — | Completed |
| Planned — Approximate Date | ||||
2/2/2026 | 16.82K | $29.1K | NASDAQ | Planned |
| Total | 17.61K | $30.0K | ||